Brett Ryan Murphy
Outfitter in Collbran, CO
License number
Colorado 3011
Issued Date
Mar 12, 2015
Renew Date
Apr 1, 2016
Expiration Date
Mar 31, 2017
Type
Outfitter
Address
Address
PO Box 184, Collbran, CO 81624
Professional information
Compounds And Therapeutic Uses Thereof
US Patent:
2013031, Nov 28, 2013
Filed:
Dec 7, 2012
Appl. No.:
13/708235
Inventors:
Jeffrey W. Lockman - Princeton Junction NJ, US
Brett R. Murphy - Collbran CO, US
Weston R. Judd - Farmington UT, US
In Chul Kim - Louisville KY, US
Se-Ho Kim - Salt Lake City UT, US
Daniel Feodore Zigar - Salt Lake City UT, US
Kraig M. Yager - Murray UT, US
Tracey C. Fleischer - Sandy UT, US
Ryan T. Terry-Lorenzo - Marlborough MA, US
J. Jay Boniface - Salt Lake City UT, US
Daniel P. Parker - Sandy UT, US
Ian A. McAlexander - Salt Lake City UT, US
Matthew Gregory Bursavich - Needham MA, US
David M. Dastrup - Columbus OH, US
Christophe Hoarau - Pleasant Hill CA, US
David A. Gerrish - Lakewood OH, US
Paul R. Sebahar - Sandy UT, US
Dange Vijay Kumar - Salt Lake City UT, US
Brett R. Murphy - Collbran CO, US
Weston R. Judd - Farmington UT, US
In Chul Kim - Louisville KY, US
Se-Ho Kim - Salt Lake City UT, US
Daniel Feodore Zigar - Salt Lake City UT, US
Kraig M. Yager - Murray UT, US
Tracey C. Fleischer - Sandy UT, US
Ryan T. Terry-Lorenzo - Marlborough MA, US
J. Jay Boniface - Salt Lake City UT, US
Daniel P. Parker - Sandy UT, US
Ian A. McAlexander - Salt Lake City UT, US
Matthew Gregory Bursavich - Needham MA, US
David M. Dastrup - Columbus OH, US
Christophe Hoarau - Pleasant Hill CA, US
David A. Gerrish - Lakewood OH, US
Paul R. Sebahar - Sandy UT, US
Dange Vijay Kumar - Salt Lake City UT, US
Assignee:
Myrexis, Inc. - Salt Lake City UT
International Classification:
C07D 213/46, C07D 295/135, C07D 235/06, C07D 401/12
US Classification:
5142355, 546332, 514357, 546261, 514335, 5462754, 514341, 546194, 514318, 546265, 514332, 5483044, 514394, 5462764, 514343, 5462727, 544284, 51426621, 544360, 435375, 51425301, 544131
Abstract:
The invention relates to compounds, pharmaceutical compositions and methods useful for treating cancer, systemic or chronic inflammation, rheumatoid arthritis, diabetes, obesity, T-cell mediated autoimmune disease, ischemia, and other complications associated with these diseases and disorders.
Compounds And Therapeutic Uses Thereof
US Patent:
2012032, Dec 27, 2012
Filed:
Aug 31, 2012
Appl. No.:
13/601879
Inventors:
J. Adam Willardsen - Draper UT, US
Jeffrey W. Lockman - Princeton Junction NJ, US
Brett R. Murphy - Collbran CO, US
Weston R. Judd - Farmington UT, US
In Chul Kim - Louisville KY, US
Se-Ho Kim - Salt Lake City UT, US
Daniel Feodore Zigar - Salt Lake City UT, US
Kraig M. Yager - Murray UT, US
Tracey C. Fleischer - Sandy UT, US
Ryan T. Terry-Lorenzo - Marlborough MA, US
J. Jay Boniface - Salt Lake City UT, US
Daniel P. Parker - Sandy UT, US
Ian A. McAlexander - Salt Lake City UT, US
Matthew Gregory Bursavich - Needham MA, US
David M. Dastrup - Columbus OH, US
Jeffrey W. Lockman - Princeton Junction NJ, US
Brett R. Murphy - Collbran CO, US
Weston R. Judd - Farmington UT, US
In Chul Kim - Louisville KY, US
Se-Ho Kim - Salt Lake City UT, US
Daniel Feodore Zigar - Salt Lake City UT, US
Kraig M. Yager - Murray UT, US
Tracey C. Fleischer - Sandy UT, US
Ryan T. Terry-Lorenzo - Marlborough MA, US
J. Jay Boniface - Salt Lake City UT, US
Daniel P. Parker - Sandy UT, US
Ian A. McAlexander - Salt Lake City UT, US
Matthew Gregory Bursavich - Needham MA, US
David M. Dastrup - Columbus OH, US
Assignee:
Myrexis, Inc. - Salt Lake City UT
International Classification:
A61K 31/549, C12N 5/02, A61K 31/5377, A61K 31/50, A61K 31/519, A61K 31/47, A61K 31/4545, A61K 31/4406, A61K 31/4402, A61K 31/357, A61K 31/17, C07D 417/12, C07D 413/12, C07D 237/20, C07D 471/04, C07D 215/46, C07D 401/12, C07D 211/98, C07D 211/04, C07D 317/46, C07C 275/40, A61P 35/00, A61P 29/00, A61P 19/02, A61P 3/04, A61P 3/10, A61P 9/10, C12Q 1/02
US Classification:
5142232, 435 29, 435375, 5142355, 514247, 5142641, 514313, 514318, 514352, 514357, 514466, 514597, 544 13, 544131, 544224, 544279, 546162, 546194, 546312, 546330, 546331, 549441, 564 49
Abstract:
The invention relates to compounds, pharmaceutical compositions and methods useful for treating cancer, systemic or chronic inflammation, rheumatoid arthritis, diabetes, obesity, T-cell mediated autoimmune disease, ischemia, and other complications associated with these diseases and disorders.